Journal of Bacteriology, August 2004, p . 5167-5171, Vol . 186, No . 15

The ompU Paralogue vca1008 Is Required for Virulence of Vibrio cholerae

Carlos G . Osorio,¹ Hector Martinez-Wilson,² and Andrew Camilli^2*

Tufts University Medical School, Tufts University, Boston, Massachusetts 02111,² Programa de Microbiología y Micología, Facultad de Medicina, Universidad de Chile, Santiago, Chile¹

Received 19 January 2004/ Accepted 5 May 2004

 
We made single and combined mutations in ompU, ompT, and the two putative porin genes vca1008 and vc0972 . The fitness of the strains was tested in vitro and in the infant mouse model of intestinal infection . We also studied the transcriptional induction of vca1008 in vitro and during mouse infection . We show that vca1008 is induced during infection and is necessary and sufficient (in the absence of ompU, ompT, and vc0972) for infection .

 
Vibrio cholerae is a gram-negative bacterium and facultative pathogen that can cause an acute secretory diarrhea known as cholera . When V . cholerae enters a host it has to sense the new environment and induce an adaptive response that facilitates its survival and multiplication in the small intestine . ToxR is a transmembrane transcriptional activator that is part of a complex virulence gene regulon (the ToxR regulon) of more than 20 genes (9, 12, 17) . The ToxR regulon is organized in two separate branches: the toxT-dependent and the toxT-independent branches . In the toxT-dependent branch, the transcriptional activator ToxT, controlled directly by ToxR, regulates the transcription of the cholera toxin and toxin-coregulated pilus and other factors essential for virulence (3) . The toxT-independent branch includes two outer membrane porins called OmpU and OmpT (9) . These two porins are directly and differentially regulated by ToxR in that ompU transcription is induced, whereas ompT transcription is repressed (2, 6, 9) . There are some studies that suggest important functions for ompU during intestinal colonization, namely, increased resistance to bile and anionic detergents (13, 14), an organic acid tolerance response (7), and adhesion to epithelial cells (18) . However, one study reported that OmpU does not mediate adherence to rabbit intestinal epithelia (11), and another study reported that ompU and ompT strains exhibited no growth defect in vitro nor any detectable attenuation of virulence in infant mice (14) .

We recently used the recombination-based in vivo expression technology (RIVET) (1) to identify V . cholerae gene vca1008 as being transcriptionally induced during infection of the infant mouse small intestine (C . Osorio, J . Crawford, J . Michalsky, H . Martinez-Wilson, J . Kaper, and A . Camilli, unpublished data) . This gene is one of three putative porin genes located on chromosome (Chr) II, and it encodes a protein that is closely related to the Chr I-encoded OmpU porin, having 33% identity and 55% similarity . The other Chr II-encoded putative porins, OmpS and OmpW, are orthologues of the Escherichia coli maltose-specific LamB and uncharacterized OmpW, respectively . The OmpU and VCA1008 paralogues are more closely related to the E . coli nonspecific porins OmpF, OmpC, and PhoE than are the other putative or known porins of V . cholerae (Fig . 1) . In contrast, V . cholerae OmpT and VC0972 porins are only distantly related to these proteins (Fig . 1) .

 
The relatedness of OmpU and VCA1008 leads to the possibility of an overlap in their function, which might explain why mutations in ompU alone fail to attenuate virulence in the infant mouse host . To test this hypothesis and also to characterize the roles of porins OmpT and VC0972, we constructed single and combined in-frame deletions in each of these genes (see Table 1 for strains and plasmids used in the present study) . In-frame deletions of the entire coding sequence of V . cholerae genes were constructed in pCVD442 by using splicing by overlap extension (SOE) PCR (16) with the oligonucleotide primers listed in Table 2 . Each recombinant pCVD442 was electroporated into E . coli SM10pir and transferred to V . cholerae GOA1264 by conjugation . Allelic exchange was done as described previously (4), and the chromosomal deletion mutations were confirmed by PCR with F0 and R2 primers (Table 2), followed by DNA sequencing (data not shown) . For complementation experiments, vca1008 was amplified twice independently from GOA1264 genomic DNA by using the primer pairs GOA3-GOA4 and GOA5-GOA6 . The products were cloned into pMMB67EH-neo digested with EcoRI and XbaI, producing pVCA1008-F and pVCA1008-R, respectively .

 
We observed no detectable growth defect in Luria-Bertani (LB) broth for the single deletion strain vca1008, double-deletion strains ompU vca1008 and ompT vc0972, or the triple-deletion strain ompU ompT vc0972 (data not shown) . We were unable to construct the quadruple deletion strain, suggesting that the loss of all four porins is lethal to V . cholerae; however, this was not rigorously examined .

The single and combined deletion strains were each examined for growth in LB broth and infection of infant mice in competition assays with the virulent LacZ^– strain GOA6W . Each test strain was grown to mid-exponential phase in LB broth plus 10 µg of rifampin (Rif) ml^–1 and then mixed 1:1 with the similarly grown GOA6W . Approximately 10⁵ CFU were inoculated intragastrically into 10 5-day-old mice as previously described (1) . In vitro competitions were done in parallel by using each of the prepared inoculae to inoculate 2 ml of LB broth with 10⁴ CFU, after which the cultures were grown for 16 h at 37°C with aeration . The ratio of test strain to GOA6W in each inoculum, as well as in the resulting bacterial populations recovered from the in vitro and from the in vivo competitions after 16 and 24 h, respectively, was determined by plating serial dilutions of the outputs onto LB agar plus 10 µg of Rif and 40 µg of X-Gal (5-bromo-4-chloro-3-indolyl-ß-D-galactopyranoside) ml^–1 . The competitive indices (CI) were calculated by dividing the output ratios of test strain to GOA6W by their respective input ratios . For complementation tests, strain GOA1713 was electroporated with plasmids pMMB67EH-neo, pVCA1008-F, and pVCA1008-R .

As shown in Table 3, strain vca1008 was attenuated 40-fold for the infection of infant mice, indicating that this putative porin is necessary for infection . The vca1008 ompU double-deletion strain was not significantly different from strain vca1008, a finding consistent with ompU being dispensable for infection . The vca0972 ompT strain was not significantly different from the wild-type, indicating that neither gene is required for infection and also that these two related proteins do not constitute a functionally redundant pair with an important role in infection . Finally, the ompU ompT vc0972 triple deletion strain outcompeted the parental strain by 13-fold . Together, these data suggest that vca1008 is necessary and sufficient (in the absence of ompU, ompT, and vc0972) for virulence . To test for the occurrence of a spontaneous mutation in the vca1008 strain that could be causing the observed avirulent phenotype, we complemented this strain with a wild-type copy of vca1008 and its native promoter cloned in the low-copy plasmid pMMB67EH-neo . The presence of empty vector alone did not restore virulence (data not shown) . However, as shown in Table 3, both orientations of vca1008 in the plasmid fully restored virulence, although to slightly higher levels than that of the parent strain when vca1008 was in the same orientation as the P_tac promoter . It is possible that vca1008 is being overexpressed when cloned in this orientation .

 
Transcriptional induction of vca1008 in vivo would be consistent with the important role we have ascribed to this gene for infection of infant mice . To test this, we measured induction of vca1008 after growth in vitro and after infection of infant mice by using RIVET essentially as described previously (1) . The resolvase gene fusion to vca1008 (vca1008::tnpR¹³⁵ [5a]) was reconstructed in a fresh reporter strain background (GOA1245), which harbors the res-neo-sacB-res substrate cassette for resolvase, to generate strain GOA1705 (see Table 1) . GOA1705 was grown for ca . 17 generations at 37°C with aeration to stationary phase in M9 minimal medium with or without 0.1% D-glucose and in LB broth or was used to infect infant mice for 24 h as described previously (1) . Transcriptional induction of vca1008::tnpR¹³⁵ results in production of resolvase protein (TnpR), which in turn excises the res-neo-sacB-res cassette from the genome, yielding a kanamycin-sensitive, sucrose-resistant strain phenotype . Serial dilutions of the final cultures and the mouse small intestinal homogenates were plated on LB agar plus 10 mg of Rif ml^–1 and on L-agar without NaCl but with 10% sucrose plus 10 mg of Rif ml^–1 . The percentage of resolved V . cholerae cells within each test population was calculated by dividing the number of CFU on sucrose plates by the CFU on the LB plates . The vca1008::tnpR¹³⁵ fusion was expressed during infection of infant mice but not during growth in vitro in either minimal or rich medium . The resolution levels of the GOA1705 (vca1008::tnpR¹³⁵ res-neo-sacB-res) strain, measured as the percent CFU resolved (see above), were as indicated under the following growth conditions: M9 with glucose, <0.1%; M9 without glucose, <0.1%; LB medium, <0.1%; and in vivo, 75 to 80% . Note that, in vivo, the outputs from four mice were assayed separately, and the range of resolution is shown . The resolution in vivo was significantly greater than during growth in vitro, as determined by the Student two-tailed t test .

It is possible that vca1008 is upregulated in the triple-gene-deletion strain to allow viability and enhanced virulence . This would be consistent with the following observations: (i) we were unable to delete vca1008 in the triple-gene-deletion strain background (data not shown), (ii) different expression levels of vca1008 from a plasmid can restore virulence to the vca1008 chromosomal deletion strain to near or greater than wild-type levels (see complementation analysis above), and (iii) vca1008 is transcriptionally silent during growth in vitro in the wild-type strain background and thus would presumably require upregulation in the triple-gene-deletion background from which is cannot be deleted . To examine whether VCA1008 (or other porins) are upregulated in the triple-gene-deletion strain, we analyzed the outer membrane protein profiles of this and other strains generated in the present study by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) . Outer membrane proteins were purified from mid-exponentially growing cells in LB broth at 37°C with aeration as described previously (15) . Proteins were separated on 4 to 12% gradient SDS-PAGE gels and stained with Coomassie brilliant blue . There were no detectable changes in the outer membrane protein profiles for the vca1008 strain or the ompT vc0972 strain compared to the wild-type (Fig . 2) . In contrast, the ompU strain and the ompU vca1008 double-deletion strain were both missing the band corresponding to OmpU . This was confirmed by Western blotting with anti-OmpU polyclonal antiserum (data not shown) . Analysis of the ompU ompT vc0972 strain revealed the appearance of a new band migrating at roughly the same position as OmpU but at a slightly lower intensity (Fig. 2, lane 7) . This new band also cross-reacted with the anti-OmpU serum upon Western blotting (data not shown) . We hypothesize that this new protein species represents VCA1008, which has been upregulated in the triple-gene-deletion background . VCA1008 has 33% identity and 55% similarity to OmpU and has an estimated molecular mass nearly identical to that of OmpU . To confirm that ompU was deleted in this strain, we isolated genomic DNA and PCR amplified a DNA fragment predicted to span the ompU deletion junction by using the primers ompUF0 and ompUR0 . These primers hybridize to sequences outside the regions cloned for ompU deletion construction by SOE . A PCR product of the size expected for the deletion was obtained, and sequencing of the PCR product revealed the expected deletion junction (data not shown) . Thus, ompU has been deleted from this strain .

 
Despite the sequence similarity of VCA1008 to OmpU and its apparent cross-reactivity with anti-OmpU antibodies, VCA1008 and OmpU are not functionally redundant, as we had originally speculated . The vca1008 gene is the only one of the four encoding known or putative porins tested in the present study that is necessary for infection of infant mice . Thus, either the activity of VCA1008 or its pattern of expression during infection, or both, are different from that of OmpU . It is known that OmpU porin increases the resistance to bile and anionic detergents (13, 14) and has a role in resistance to organic acids (7) . Perhaps VCA1008 is more efficient in one or more of these functions or, alternatively, fulfills another, unknown role during infection .

The transcriptional induction of vca1008 was investigated and was shown to be induced during infection but not during growth in minimal or rich media . These results indicate that the induction observed in vivo is not a result of a general stress response to nutrient deprivation, as might occur within the small intestine, but rather a kind of specific response to intestinal infection . This result is unexpected, given that Xu et al . (19) reported vca1008 to be repressed during infection of rabbit ligated ileal loops . These conflicting results may be due to the use of different animal hosts, the use of ligated ileal loops as opposed to an unrestricted intestinal tract, or the use of transcriptional profiling, which provides an average value of gene expression .

 
This study was supported by Pew Latin American Fellowship grant PO337SC (C.G.O.) and National Institutes of Health grant AI45746 (A.C.) .

 
* Corresponding author . Mailing address: Tufts University Medical School, Tufts University, Boston, MA 02111 . Phone: (617) 636-2144 . Fax: (617) 636-0337 . E-mail: andrew.camilli@tufts.edu .

1. Camilli, A., and J . J . Mekalanos. 1995 . Use of recombinase gene fusions to identify Vibrio cholerae genes induced during infection . Mol . Microbiol . 18:671-683.
2. Crawford, J . A., J . B . Kaper, and V . J . DiRita. 1998 . Analysis of ToxR-dependent transcription activation of ompU, the gene encoding a major envelope protein in Vibrio cholerae . Mol . Microbiol. 29:235-246.
3. DiRita, V . J., C . Parsot, G . Jander, and J . J . Mekalanos. 1991 . Regulatory cascade controls virulence in Vibrio cholerae . Proc . Natl . Acad . Sci . USA 88:5403-5407.
4. Donnenberg, M . S., and J . B . Kaper. 1991 . Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector . Infect . Immun . 59:4310-4317.
5. Kolter, R., M . Inuzuka, and D . R . Helinski. 1978 . Trans-complementation-dependent replication of a low molecular weight origin fragment from plasmid R6K . Cell 15:1199-1208.
5. Lee, S . H., D . L . Hava, M . K . Waldor, and A . Camilli. 1999 . Regulation and temporal expression patterns of Vibrio cholerae virulence genes during infection . Cell 99:625-634.
6. Li, C . C., D . S . Merrell, A . Camilli, and J . B . Kaper. 2002 . ToxR interferes with CRP-dependent transcriptional activation of ompT in Vibrio cholerae . Mol . Microbiol . 43:1577-1589.
7. Merrell, D . S., C . Bailey, J . B . Kaper, and A . Camilli. 2001 . The ToxR-mediated organic acid tolerance response of Vibrio cholerae requires OmpU . J . Bacteriol . 183:2746-2754 .
8. Michalski, J., J . E . Galen, A . Fasano, and J . B . Kaper. 1993 . CVD110, an attenuated Vibrio cholerae O1 El Tor live oral vaccine strain . Infect . Immun . 61:4462-4468.
9. Miller, V . L., and J . J . Mekalanos. 1988 . A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR . J . Bacteriol . 170:2575-2583.
10. Morales, V . M., A . Backman, and M . Bagdasarian. 1991 . A series of wide-host-range low-copy-number vectors that allow direct screening for recombinants . Gene 97:39-47.
11. Nakasone, N., and M . Iwanaga. 1998 . Characterization of outer membrane protein OmpU of Vibrio cholerae O1 . Infect . Immun . 66:4726-4728 .
12. Peterson, K . M., and J . J . Mekalanos. 1988 . Characterization of the Vibrio cholerae ToxR regulon: identification of novel genes involved in intestinal colonization . Infect . Immun . 56:2822-2829 . (Erratum, 57:660, 1989.)
13. Provenzano, D., and K . E . Klose. 2000 . Altered expression of the ToxR-regulated porins OmpU and OmpT diminishes Vibrio cholerae bile resistance, virulence factor expression, and intestinal colonization . Proc . Natl . Acad . Sci . USA 97:10220-10224 .
14. Provenzano, D., C . M . Lauriano, and K . E . Klose. 2001 . Characterization of the role of the ToxR-modulated outer membrane porins OmpU and OmpT in Vibrio cholerae virulence . J . Bacteriol . 183:3652-3662 .
15. Russel, M., and B . Kazmierczak. 1993 . Analysis of the structure and subcellular location of filamentous phage pIV . J . Bacteriol . 175:3998-4007.
16. Senanayake, S . D., and D . A . Brian. 1995 . Precise large deletions by the PCR-based overlap extension method . Mol . Biotechnol . 4:13-15.
17. Skorupski, K., and R . K . Taylor. 1997 . Control of the ToxR virulence regulon in Vibrio cholerae by environmental stimuli . Mol . Microbiol . 25:1003-1009.
18. Sperandio, V., J . A . Giron, W . D . Silveira, and J . B . Kaper. 1995 . The OmpU outer membrane protein, a potential adherence factor of Vibrio cholerae . Infect . Immun . 63:4433-4438.
19. Xu, Q., M . Dziejman, and J . J . Mekalanos. 2003 . Determination of the transcriptome of Vibrio cholerae during intraintestinal growth and mid-exponential phase in vitro . Proc . Natl . Acad . Sci . USA 100:1286-1291 .

Free Online Full-text Article

What Is Bioremediation?, What Is Dna?, What Is Antibiotic?, What Is Botulism?, What Is Bioassay?, a, Microbes, n, Bacteriology, s, Bacteria, i, Microorganisms, s, Bacterium, i, Erwinia, o, Klebsiella, a, Escherichia coli, s, Vancomycin, s, Azithromycin, r, Prokaryotes, c, Multidrug resistant, o, Staphylococcus, s, Microbial, r, Fermentations, a, Gram negative, i, Escherichia coli, r, Propionibacteria, i, Neisseria, r, Staphylococcus aureus, n, Escherichia coli, s, Salmonella, s, Escherichia coli, e, Prokaryotes, n, Salmonella, a, Escherichia coli




 

© 2005 Transgalactic Ltd (manufacturer of Bioscreen C software) | Privacy Statement | P.O. Box 1393, 00101 Helsinki, Finland, phone: +358 9 85172920, fax: +358 9 8749481, e-mail: microbiology@bionewsonline.com
 

Last modified: May 25, 2005